| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.062 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |